These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33992860)

  • 1. Rescue immunoadsorption treatment for neuromyelitis optica spectrum disorder attacks unresponsive to intravenous methylprednisolone.
    Li R; Wang J; Li C; Liu X; Chu M; Chang Y; Wang Y; Wang X; Yu B; Ling L; Yang H; Yang H; Hu X; Qiu W
    J Neuroimmunol; 2021 Jul; 356():577604. PubMed ID: 33992860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of apheresis therapy in AQP4 antibody-positive NMOSD attack: A propensity score-matched cohort study.
    Xu Y; Wang H; Song T; Yin L; Yao Y; Wei Y; Cong H; Sun J; Zhang X; Tian DC
    CNS Neurosci Ther; 2024 May; 30(5):e14780. PubMed ID: 38790106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX.
    Songthammawat T; Srisupa-Olan T; Siritho S; Kittisares K; Jitprapaikulsan J; Sathukitchai C; Prayoonwiwat N
    Mult Scler Relat Disord; 2020 Feb; 38():101506. PubMed ID: 31731214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder.
    Yaguchi H; Sakushima K; Takahashi I; Nishimura H; Yashima-Yamada M; Nakamura M; Tsuzaka K; Maruo Y; Takahashi T; Yabe I; Sasaki H
    Intern Med; 2013; 52(9):969-72. PubMed ID: 23648715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective study of the adverse events of the treatment for an acute attack of neuromyelitis optica spectrum disorder.
    Veerachit-O-Larn T; Siritho S; Prayoonwiwat N
    Ther Apher Dial; 2020 Aug; 24(4):453-460. PubMed ID: 31709734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute bilateral cerebral infarction in the presence of neuromyelitis optica spectrum disorder: A case report.
    Wang ZY; Wang M; Guo JJ; Gao YL; Yu XF
    Medicine (Baltimore); 2020 Oct; 99(40):e22616. PubMed ID: 33019482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: Case series and review of the literature.
    Aungsumart S; Apiwattanakul M
    Mult Scler Relat Disord; 2017 Apr; 13():93-97. PubMed ID: 28427710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange.
    Abboud H; Petrak A; Mealy M; Sasidharan S; Siddique L; Levy M
    Mult Scler; 2016 Feb; 22(2):185-92. PubMed ID: 25921047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effect of plasma exchange in acute attack of neuromyelitis optica spectrum disorders.
    Srisupa-Olan T; Siritho S; Kittisares K; Jitprapaikulsan J; Sathukitchai C; Prayoonwiwat N
    Mult Scler Relat Disord; 2018 Feb; 20():115-121. PubMed ID: 29414283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Course and Treatment Response of Neuromyelitis Optica Spectrum Disease: An 8-Year Experience.
    Lin CW; Lin IH; Chen TC; Jou JR; Woung LC
    Asia Pac J Ophthalmol (Phila); 2019; 8(3):206-210. PubMed ID: 30421588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HA280 immunoadsorption, an alternative treatment for neuromyelitis optica spectrum disorders?
    Liu S; Zhou J; Liu Q; Yang Y; Li M; Man R; Yin J
    Mult Scler Relat Disord; 2020 Jan; 37():101480. PubMed ID: 31706165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoadsorption plasmapheresis treatment for the recurrent exacerbation of neuromyelitis optica spectrum disorder with a fluctuating anti-aquaporin-4 antibody level.
    Nishimura H; Enokida H; Sakamoto T; Takahashi T; Hayami H; Nakagawa M
    J Artif Organs; 2018 Sep; 21(3):378-382. PubMed ID: 29675599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing intravenous methylprednisolone pulse therapy in Chinese patients with isolated optic neuritis associated with AQP4 antibody-seropositive neuromyelitis optica.
    Guo S; Jiang H; Jiang L; Peng J; Liu H; Wang J; Wei W
    Sci Rep; 2021 Nov; 11(1):22229. PubMed ID: 34782653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoadsorption therapy for neuromyelitis optica spectrum disorders long after the acute phase.
    Kobayashi M; Nanri K; Taguchi T; Ishiko T; Yoshida M; Yoshikawa N; Sugisaki K; Tanaka N
    J Clin Apher; 2015 Feb; 30(1):43-5. PubMed ID: 24802352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-A immunoadsorption combined with immunosuppressive treatment in refractory primary Sjögren's syndrome coexisting with NMOSD: a case report and literature review.
    Fan W; Chen X; Xiao P; Wei B; Zhang Y; Huang J; Wu S; Lu L
    Front Immunol; 2024; 15():1429405. PubMed ID: 39055718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of intravenous methylprednisolone pulse therapy on optic neuritis associated with AQP4 antibody seropositive neuromyelitis optica].
    Guo ST; Li Z; Jiang LB; Wu RH; Peng JT; Wang JW; Wei WB
    Zhonghua Yan Ke Za Zhi; 2019 Mar; 55(3):180-185. PubMed ID: 30841684
    [No Abstract]   [Full Text] [Related]  

  • 18. Pontine hemorrhage accompanied by neuromyelitis optica spectrum disorder.
    Kamo H; Ueno Y; Sugiyama M; Miyamoto N; Yamashiro K; Tanaka R; Yokoyama K; Hattori N
    J Neuroimmunol; 2019 May; 330():19-22. PubMed ID: 30769213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels.
    Kim SH; Kim W; Huh SY; Lee KY; Jung IJ; Kim HJ
    J Clin Neurol; 2013 Jan; 9(1):36-42. PubMed ID: 23346159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Response and Possible Biomarkers in Acute Attacks of Neuromyelitis Optica Spectrum Disorders: A Prospective Observational Study.
    Wang J; Cui C; Lu Y; Chang Y; Wang Y; Li R; Shan Y; Sun X; Long Y; Wang H; Wang Z; Lee M; He S; Lu Z; Qiu W; Tan S
    Front Immunol; 2021; 12():720907. PubMed ID: 34421925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.